AMI Tone Up 5ml*6

AMI Tone Up | Clinical Dermal Bio-Revitalizer Medical-grade skin booster engineered for targeted hyperpigmentation correction and dermal matrix reconstruction. Formulated with high-density Sodium-DNA and plant-derived nanoscale exosomes for professional aesthetic administration. Polynucleotides (PN) Concentration: 2.5 mg/ml Molecular Weight: 1,500 kDa – 2,500 kDa Purified DNA fragments extracted from salmon germ cells. Stimulates A2A receptors, triggering immediate fibroblast proliferation and accelerating Type I and Type III collagen synthesis for dermal thickening. Vegan Exosomes Particle Size: 30nm – 150nm Source: Centella Asiatica Extracellular Vesicles Nanoscale biological lipid vesicles optimizing intercellular communication. Acts as a targeted delivery vector, bypassing the stratum corneum barrier to deliver active mRNA and growth factors directly to damaged cells. Inhibitor Complex Tranexamic Acid: Blocks plasminogen binding, inhibiting UV-induced melanogenesis. Niacinamide (5%): Prevents melanosome transfer to keratinocytes. Glutathione: Neutralizes free radicals and converts eumelanin to pheomelanin for systemic tissue brightening. CLINICAL EFFICACY METRICS (IN-VIVO DATA) 34�rmal Density -22%Melanin Index 48%Fibroblast Activity TECHNICAL SPECIFICATIONS Packaging: 5ml x 6 / Box Formulation: Sterile, clear, apirogenic aqueous solution pH Level: 6.8 – 7.5 Osmolarity: 270 – 300 mOsm/kg Storage: 2°C to 25°C. Avoid direct sunlight. Do not freeze. CLINICAL INJECTION PROTOCOL Target Layer: Mid-to-deep dermis Technique: Point-by-point micro-papule or retrograde linear threading Equipment: 30G or 32G (4mm or 13mm) Dosage per Point: 0.05ml – 0.1ml Standard Regimen: 3-4 initial sessions spaced 14-21 days apart. Maintenance session every 3-4 months. STRICT MEDICAL DISCLAIMER Professional Use Only: AMI Tone Up is a Class III medical device equivalent. Sales and administration are strictly restricted to licensed medical practitioners, dermatologists, and certified aesthetic professionals. Contraindications: Do not administer to patients with known hypersensitivity to fish-derived DNA, active cutaneous autoimmune diseases, localized infections (acne, herpes), or pregnant/lactating individuals. Compliance: Practitioners must perform comprehensive patient anamnesis and obtain informed consent prior to intervention. Strictly prohibit self-administration.